Abiopharma

🔍 Trahan Jeremy (Executive)

Company: VIEMED HEALTHCARE, INC. (VMD)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Acquired 2,986 shares of Common Shares (Direct)
  Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 24,152.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,986 shares of Common Shares at $7.31 per share (Direct)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | shares_owned_after: 21,166.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,971 shares of Common Shares (Direct)
  Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 27,137.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,634 shares of Common Shares at $7.31 per share (Direct)
  Date: 2025-08-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 25,503.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 2,986 shares of Phantom Share Units (Derivative)
  Date: 2025-08-22 | Code: M | Expires: 2025-08-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F5
• Sold 5,971 shares of Restricted Stock Units (Derivative)
  Date: 2025-08-22 | Code: M | Expires: 2025-08-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F6

Footnotes:

• F1: Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
• F2: Per share value is based on the market closing price of the common shares for August 22, 2025.
• F3: Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
• F4: Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
• F5: Represents an award granted on August 22, 2022 under the Issuer's Phantom Share Unit Plan which vested in three equal annual installments beginning on the first anniversary of the grant date.
• F6: Restricted Stock Units (RSUs) granted to reporting person on August 22, 2022, which vested in three equal annual installments beginning on the first anniversary of the grant date.